GammaDelta Therapeutics Revenue and Competitors

UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GammaDelta Therapeutics's estimated annual revenue is currently $1.4M per year.(i)
  • GammaDelta Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • GammaDelta Therapeutics has 9 Employees.(i)
  • GammaDelta Therapeutics grew their employee count by -55% last year.

GammaDelta Therapeutics's People

NameTitleEmail/Phone
1
MSAT SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is GammaDelta Therapeutics?

GammaDelta Therapeutics has been founded on pioneering research into gamma delta (??) T cells led by Professor Adrian Hayday and Dr Oliver Nussbaumer at King’s College London and the Francis Crick Institute and funded in part by Cancer Research UK. The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GammaDelta Therapeutics News

2022-04-17 - Gamma Delta T Cell Cancer Therapy Market & Clinical Trials: Market Set to Surpass $ 4 Million by 2028

The gamma delta T cell therapy represents one of the most promising T cell therapies in clinical development which can be suggested by the rapid...

2022-04-13 - Gamma Delta T Cell Therapy Represents One of the Most ...

The major companies in the market are presenting promising preclinical and clinical data of gamma delta T cell therapies.

2022-04-06 - Gamma Delta T Cell Cancer Therapy Clinical Trials Insight 2028

In recent times, gamma delta T cells have gained momentum in the field of therapeutics because they can quickly generate immune response to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M9N/AN/A
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$0.7M9N/AN/A